We have cloned a novel SOCS gene from Drosophila, socs36E, which is most homologous to the mammalian socs-5 gene. Socs36E is expressed zygotically, predominantly during embryogenesis, in a highly dynamic pattern. In vivo expression of SOCS36E in transgenic flies results in several adult phenotypes. Engrailed-GAL4 directed expression causes loss of the wing anterior cross vein, humeral outgrowths, absence of halteres and eye pigmentation defects. Expression of SOCS36E under apterous-GAL4 control resulted in outstretched wings. Full penetrance of these phenotypes required the presence of the SH2 and SOCS-box domains of SOCS36E. The observed phenotypes were consistent with defects in JAK/STAT or EGF-R signalling and were exacerbated in flies heterozygous for either the d-jak (hopscotch), dstat (stat92E) or d-egf-r (der) genes. Conversely, inactivating one copy of the d-cbl gene, a negative regulator of the d-EGF-R, partially rescued the wing phenotypes. These genetic interactions imply that SOCS36E can suppress activities of the JAK/STAT and EGF-R signalling pathways in the wing disc and suggest that SOCS36E interacts with multiple pathways in vivo.
Introduction
The duration and intensity of cytokine signalling in cells is tightly regulated to prevent abnormal accumulation of gene products. In addition to dephosphorylation by protein phosphatases (Tonks and Neel, 2001 ), a novel mechanism leading to the attenuation of diverse signalling pathways has emerged in recent years and involves a family of proteins called suppressors of cytokine signalling (SOCS). The original members of this family (also referred to as the CIS or SSI family) were identified as target genes of cytokine stimulation that functioned to suppress JANUS kinase (JAK)/signal transducer and activator of transcription (STAT) signalling in an autoregulatory loop (Endo et al., 1997; Matsumoto et al., 1997; Naka et al., 1997; Starr et al., 1997; Yoshimura et al., 1995) .
There are eight mammalian SOCS family members (CIS, SOCS-1 to SOCS-7) characterized by an Nterminal region of varying length, a central SH2 domain, and a highly conserved C-terminal 40 amino acid motif known as the SOCS-box (Hilton et al., 1998) . The SOCS proteins can be subdivided into two groups; those with short N-termini (CIS, SOCS-1 -3) and those with longer N-termini (SOCS-4 -7) (Hilton et al., 1998) . To date, much of the studies have focused on CIS and SOCS-1 -3. In addition to regulating JAK/STAT activity, they have been shown to suppress c-kit (De Sepulveda et al., 1999) , PDGF (Cacalano et al., 2001) , insulin (Emanuelli et al., 2000) and IGF-I (Metcalf et al., 2000) signalling and can facilitate the activation of the Ras/MAPK pathway (Cacalano et al., 2001) . Their pleiotropic activity coupled with their wide tissue distribution (Hilton et al., 1998) suggest that SOCS proteins are general regulators of signalling pathways and will possess additional functions distinct from those already described.
While our knowledge of CIS and SOCS-1 -3 is considerable, little is known about the function(s) of SOCS-4 -7. To better understand their biological function, we took the approach of studying a novel SOCS protein isolated from Drosophila melanogaster that is highly homologous to SOCS-5. As signalling pathways between flies and vertebrates are extensively conserved, we reasoned that interactions between Drosophila SOCS (d-SOCS) proteins and signalling pathways in this organism will be predictive of the function(s) of SOCS proteins in mammals.
Here we provide the first characterization of a SOCS protein in Drosophila. Socs36E is expressed zygotically in a highly dynamic pattern during embryogenesis. Based on its expression profile and ectopic expression experiments using transgenic flies, we provide evidence that like its mammalian counterparts, SOCS36E can suppress JAK/STAT signalling in flies. In addition, we observed a genetic interaction between SOCS36E and the Drosophila epidermal growth factor receptor (d-egf-r) pathway in the wing disc. Structure/function analyses in vivo indicate that the SH2 domain of SOCS36E is necessary for the interaction with biological targets, and that the SOCS-box is essential for maximal activity in vivo.
Results

Socs36E encodes a 3.5 kb embryonic transcript
To determine the function of SOCS proteins in D. melanogaster, we isolated a 3.5 kb cDNA from an embryonic cDNA library that encodes a protein with significant homology to the SOCS protein family (Figure 1a) . The 1.9 kb open reading frame (ORF) in this cDNA encodes a protein of 634 amino acids with the SH2 and SOCS-box domains being 81% similar (68% identical) to the corresponding regions of human SOCS-5 (Figure 1b) . Its N-terminus, however, is unique and shows no significant homology with vertebrate SOCS proteins (Figure 1b) . We refer to this gene as socs36E (based on its cytological location on chromosome 2).
The sequence in our cDNA confirms for the most part, the current genomic organization for the CG15154 gene (corresponding to socs36E) annotated in Flybase with one exception. Our cDNA predicts four separate exons, spread over a 13.7 kb region, with a large 9.5 kb intron separating exons 1 and 2 ( Figure  1c ). In contrast, the current annotation for CG15154/ socs36E failed to recognize exon 1 present in our cDNA, predicting only the three exons corresponding to exons 2, 3 and 4 in our clone. Northern blot analysis on total RNA isolated from embryos as well as from the fly Schneider S2 cell line confirmed that we had obtained a full length cDNA. A 3.5 kb transcript is detected in embryos and S2 cells; a faster migrating transcript of about 2.3 kb is also observed in S2 cells ( Figure 2a) . Next, we analysed the expression of socs36E mRNA during development (Figure 2b ). The 3.5 kb transcript is the predominant form and is expressed throughout development. A faint 2.3 kb band (likely identical to the shorter transcript in S2 cells) is detected at times when the 3.5 kb transcript is maximally expressed (Figure 2b , lane 3). Socs36E mRNA is zygotically expressed, with maximal levels between 2 and 12 h of embryonic development. The socs36E mRNA level rapidly declines at the end of embryogenesis and remains low during larval stages with a modest increase during pupal development. Socs36E transcripts are not readily detected in adults when total RNA is used.
The coding region of our cDNA was modified by fusing a HA-tag to the presumptive N-terminal region of SOCS36E. This construct (under control of the Actin-5C promoter) was stably transfected into fly mbn-2 cells. Full length HA-tagged SOCS36E protein was detected in these cells, confirming the presence of a translatable ORF in our cDNA clone (Figure 2c) .
In situ hybridization with sense and anti-sense socs36E RNA probes revealed a highly dynamic pattern of expression for socs36E during embryogenesis (Figure 3) . It is first detected in a broad domain in stage 5 embryos (data not shown). This broad domain becomes restricted to a series of stripes before being further refined to segmental stripes in the mesoderm (Figure 3a -d) . At later stages of embryogenesis, socs36E mRNA expression is enriched at the anterior and posterior ends of the embryo (Figure 3e ) where the proventriculus and anterior midgut, and posterior midgut and hindgut join, respectively. No staining above background was observed with the control sense probe (Figure 3f ).
Ectopic expression of SOCS36E in vivo
In the absence of available socs36E mutants, we initially attempted to evaluate the function of socs36E in embryos using RNA interference (RNAi) to abolish socs36E mRNA. Cuticle preparations of mock and socs36E RNAi injected embryos showed no dramatic differences, suggesting that loss of socs36E expression had no overt embryonic phenotype (data not shown). However, given the high level of socs36E RNA in embryos, it is possible that our approach failed to destroy all the endogenously expressed socs36E mRNA. The potential function(s) of SOCS36E was next examined in vivo following ectopic expression using the UAS-GAL4 binary system (Brand and Perrimon, 1993) . Concurrently, we evaluated the role of the SOCS-box and the SH2 domain in mediating SOCS36E activity. We generated several transgenic lines of flies carrying either wild-type or mutant forms of socs36E under the control of the upstream activation sequence (UAS) of the yeast transcription factor GAL4 (Figure 1d ). For the first mutant (SH2*), we substituted a conserved arginine in the SH2 domain (Arg
500
) with lysine to cripple the ability of this region to bind phosphorylated tyrosine residues (Kamura et al., 1998; Marengere and Pawson, 1992; Mayer et al., 1992) . In the second mutant (DSB), the conserved SOCS-box was deleted in its entirety. We refer to these stocks as UAS-SOCS, UAS-SOCS-SH2* and UAS-SOCS-DSB, respectively.
We crossed our UAS-SOCS stocks with various fly stocks that express GAL4 under the control of different promoters and checked for any effects in the ensuing progeny. Ubiquitous SOCS36E expression directed by Actin5C-GAL4 did not result in strong adult phenotypes save for occasional wing vein defects. However, the lifespan of the progeny was significantly shorter (data not shown). Early expression of SOCS36E protein directed by two different maternal GAL4 lines did not interfere with embryogenesis. However, the expression of SOCS36E under the regulation of either apterous-GAL4 (ap-GAL4) or engrailed-GAL4 (en-GAL4) resulted in highly reproducible adult phenotypes (Figure 4 ). Ninety-four per cent of ap-GAL4/ UAS-SOCS flies showed an outstretched wing phenotype ( Figure 4A, panel a) . This phenotype requires an intact SH2 domain in SOCS36E as expression of SOCS36E-SH2* with ap-GAL4 failed to produce any phenotype (data not shown).
Directed expression of SOCS36E with en-GAL4 resulted in several defects in the wing, notum and the eye (Figures 4, 5 and Table 1 ). Ninety-nine per cent of the flies exhibited a loss of the anterior cross vein (ACV) in the wing and occasional wing vein deltas were also observed (Figure 5b ). Nearly 40% of flies had humeral outgrowths ( Figure 4A , panel b). Penetrance of this phenotype was more variable and was highest when flies were reared at 298C where GAL4-transcriptional activity is higher. In 10 to 20% of cases, there was a partial or total loss of halteres (data not shown). Again, the frequency was maximal at higher temperature. Lastly, the progeny between en-GAL4 and all of Figure 4A , panel c). The eye pigmentation effect is specific to SOCS36E protein expression. It is not observed with any other GAL4 line used to drive SOCS36E expression or in flies derived from crosses between en-GAL4 and other unrelated UAS-constructs available in the lab (data not shown). Interestingly, this phenotype is not the result of an SH2-mediated interaction as it is also observed with SOCS36E-SH2* (Table 1) .
The higher penetrance of many of the phenotypes observed at higher temperatures suggested that an increase in socs36E gene dosage would result in more severe phenotypes. To test this, we increased the copy number of both en-GAL4 and the UAS-SOCS transgenes in the progeny. Despite the cross being performed at 208C, we observed significant toxicity as manifest by the presence of many adults that failed to eclose from their pupal case (pharate adults). Furthermore, the few viable adults that had received two copies of both transgenes exhibited all previously noted phenotypes, albeit at higher penetrance: missing anterior cross veins (100%), humeral outgrowths (70%) and missing halteres (54%). In addition, we observed ectopic wing vein material in 70% of the flies (Figure 5c ), and in 12% of cases, flies exhibited severe wing and notum defects ( Figure  4A , panel d).
En-GAL4 directed expression of mutant SOCS36E proteins led to both quantitative and qualitative phenotypic differences. The presence of an intact SH2 region in SOCS36E was required for the majority of phenotypes, save the eye pigmentation defect (Table  1) . Deleting the SOCS-box had a modest effect, and was largely quantitative. When the SOCS36E-DSB protein was expressed, the penetrance of the missing ACV phenotype was little affected, whereas the incidence of humeral outgrowths declined to 17% (compared to 38% with SOCS36E, Table 1 ). A similar reduction was observed for the haltere phenotype (data not shown).
Genetic interaction with the JAK/STAT pathway
Many defects in the wing and notum that occur when SOCS36E is expressed under engrailed or apterous (Yan et al., 1996) , while humeral outgrowths have been observed in a conditional mutant of stat92E (Baska et al., submitted). In addition, the outstretched phenotype in ap-GAL4/UAS-SOCS flies is similar to that observed with certain regulatory alleles of unpaired (upd), a gene which encodes a ligand in the JAK/STAT pathway in flies (Harrison et al., 1998) . To underscore a possible genetic interaction between SOCS36E and this pathway, we examined whether expression of SOCS36E in flies that were heterozygous for a given gene in the JAK/STAT pathway led to more severe phenotypes. The expression of SOCS36E under en-GAL4 regulation in stat92E+/7 flies had no effect on the loss of the ACV. However, we observed ectopic venation in wings in 60% of these flies as opposed to 2% in stat92E+/+ flies ( Figure 6a ; Table 2 ). The humeral outgrowth phenotype was also exacerbated in stat92E heterozygous flies (compare Figure 4B , panel a; with Figure 4A , panel b). Microscopic examination of the outgrowth suggests it is comprised of wing material ( Figure 4B, panel b) . Inactivating one copy of the hopscotch (hop) gene, the fly ortholog of jak, had a Several independent UAS-SOCS36E-WT or mutant transgenic lines (n) were crossed to the en-GAL4 driver (e16e) at 278C. The F1 adults from these crosses were scored for absent wing ACVs and humeral outgrowths, as described in the text. The data is expressed as mean+s.e.m. similar effect on ectopic vein formation, though the penetrance was not as high as with stat92E+/7 flies (17 -26% versus 60%; Figure 6b ). Likewise, the size and incidence of the humeral outgrowth phenotype was also increased (data not shown). Thus, it appears that SOCS36E, when expressed under en-GAL4 regulation, interferes with the activity of the JAK/STAT pathway in the wing and notum.
SOCS36E rescues toxicity associated with ectopic Hop expression
Expression of Hop using en-GAL4 is lethal. As SOCS36E appeared to negatively regulate the JAK/ STAT pathway in flies, we examined whether we could counteract this lethality by co-expressing SOCS with Hop. In contrast to the lethality with Hop alone, viable flies emerged at a frequency of 22% (33% expected if no toxicity) when SOCS36E and Hop were coexpressed. Co-expressing GFP and Hop under identical conditions failed to rescue the Hop-associated lethality. Therefore, the effect observed with SOCS36E is specific and not due to a reduced expression level of Hop due to the co-expression of two UAS constructs with en-GAL4. Interestingly, there was full restoration of the ACV in wings of viable flies expressing both Hop and SOCS36E ( Figure 6c ). In contrast, co-expression of GFP with SOCS36E completely failed to restore the missing ACV ( Figure 6 , panel d). Additional phenotypes observed in flies that co-expressed Hop and SOCS36E (e.g. thickening of the L3 vein ( Figure 6 , panel c, and data not shown)) are likely due to ectopic Hop expression.
Genetic Interaction with the Drosophila epidermal growth factor receptor (DER) pathway
Loss of the ACV and partial thinning of the L4 vein have been described in certain hetero-allelic combinations of the d-egf-r (der) (Clifford and Schupbach, 1994) . Furthermore, expression of a dominant negative form of d-fos with en-GAL4 results in the complete absence of the ACV in the wings of the affected flies (Ciapponi et al., 2001) , presumably by interfering with the EGF-R pathway. The similarity of these phenotypes with the wing phenotype observed in en-GAL4/ UAS-SOCS flies prompted us to examine whether SOCS36E could also interact with the EGF-R pathway. The expression of SOCS36E under en-GAL4 regulation in flies heterozygous for the d-egf-r had no effect on the ACV phenotype. However, wings from 86% of these flies showed ectopic wing vein material and an occasional thinning of a section of the L4 longitudinal wing vein (27%) (Figure 6e and f) . In contrast, inactivating one copy of the d-cbl gene, a negative regulator of the EGF-R, partially rescued the ACV defect. Under these conditions, the penetrance of the ACV phenotype was halved from 95 to 48%; Table 3 ). Similarly, the incidence of the outstretched wing phenotype was reduced from 82 to 54% when SOCS36E was expressed under ap-GAL4 control in dcbl+/7 flies. Taken together, these results suggest that SOCS36E can also functionally suppress EGF-R signalling in the developing wing. Interestingly, both the severity and penetrance of the humeral outgrowth phenotype were unaffected in der+/7 or cbl+/7 flies. UAS-SOCS-45; TM3, Sb/stat 1681 flies were crossed to the en-GAL4 driver (e16e) at 278C. The F1 adults from this cross were scored for ectopic wing vein material and humeral outgrowths as described in the text
Discussion
Socs36E is zygotically expressed, primarily during embryogenesis, where it is detected mainly as a 3.5 kb transcript. Although this issue needs to be examined more thoroughly, socs36E expression, like several of its mammalian orthologues (Endo et al., 1997; Matsumoto et al., 1997; Naka et al., 1997; Starr et al., 1997; Yoshimura et al., 1995) , may be regulated by the JAK/STAT pathway. First, its expression pattern initially overlaps that of the upd gene, which encodes a ligand of the JAK/STAT pathway in flies (Harrison et al., 1998) . Second, we have found that socs36E mRNA expression is increased in larvae carrying a gain of function mutation in the JAK/ STAT pathway (data not shown).
The role of the SH2 and SOCS-box domains of SOCS36E was evaluated in vivo. Save for the eye phenotype observed in our experiments, the bulk of SOCS36E activity requires a functional SH2 domain. To our surprise, deletion of the SOCS-box resulted only in a modest decrease in SOCS36E activity in vivo. As the SOCS-box is a highly conserved motif (Hilton et al., 1998) , we had anticipated that a SOCS-box deleted protein would either be inactive or act as a dominant negative in vivo. However, this was not the case. Our results are consistent with the observation that knock-in mice expressing a SOCS-box deficient SOCS-1 protein die of hyper-interferon-gamma (IFNg) sensitivity at a slower rate than SOCS-17/7 mice (Zhang et al., 2001) . In this case, as well as SOCS-1, the SOCS-box is necessary for full activity in vivo. Together, these results indicate that the functional significance of the SOCS-box has been conserved from flies to vertebrates.
Ectopic expression of SOCS36E in vivo was usually well tolerated and, in most cases, caused no obvious phenotype. However, we observed highly reproducible adult phenotypes when SOCS36E expression was directed by en-GAL4. There was a fully penetrant loss of the wing ACV as well as non-uniform mini-white pigmentation in the eye. In addition, we observed humeral outgrowths and partial or total loss of halteres in a significant percentage of viable adult flies.
Expression of SOCS36E under the control of dpp-GAL4 (dpp is a target of Engrailed in the wing disc) resulted only in loss of the ACV, and its frequency was much reduced (31 vs 99% for en-GAL4; data not shown). Flies carrying two copies of the en-GAL4 enhancer trap and two copies of the UAS-SOCS transgene showed reduced viability. Viable flies displayed a higher incidence of humeral outgrowths and loss of halteres, and in 12% of cases severe notum and wing defects. Thus, both the severity and penetrance of adult phenotypes showed a tight gene dosage dependency.
The specific loss of the ACV is intriguing. At least three pathways have been implicated in playing a role in cross vein development. Mutations in the EGF-R, Notch or BMP-like pathways have been shown to affect both anterior and posterior cross veins, with some effect on longitudinal veins as well (Conley et al., 2000; Khalsa et al., 1998) . Whether the specification and development of the ACV differ from that of the posterior cross vein (PCV) is unclear. However, during development, it appears that an ACV-like provein is formed before any PCV provein is visible (Conley et al., 2000) . Our data supports the existence of a differential requirement for the two cross veins to be formed and suggest that SOCS36E interferes with the activity of a crucial component in this process. Ectopic expression of dominant negative d-fos, under en-GAL4 regulation also results in the specific loss of the ACV, presumably by reducing EGF-R/extracellular regulated kinase (ERK) activity (Ciapponi et al., 2001) . A link between SOCS36E and the EGF-R signalling is suggested by the genetic interaction observed in the wing. Expressing SOCS36E under en-GAL4 control in flies heterozygous for the egf-r, results in ectopic venation in the posterior portion of the wing. In 27% of these flies, there is also a partial loss or thinning of a segment of the L4 longitudinal vein, a phenotype seen in certain heteroallelic combinations of egf-r mutants (Clifford and Schupbach, 1994) . Furthermore, removing a single copy of the d-cbl gene, a negative regulator of the EGF-R (Pai et al., 2000) , partially rescued the ACV phenotype in UAS-SOCS/en-GAL4 flies. Together, these results suggest that SOCS36E interacts with and interferes with EGF-R signalling in the wing. Ectopic wing venation was also detected when SOCS36E was expressed under en-GAL4 control in stat92E+/7 flies. This is strikingly similar to what was seen in flies homozygous for stat92E HJ , a weak allele of d-stat (Yan et al., 1996) . Thus, both EGF-R and STAT activities are important in restricting the field of vein territories in the wing. It is unlikely that the EGF-R activates d-STAT directly since removing one copy of the hop gene also resulted in ectopic wing venation. This suggests that Hop is a likely intermediate downstream of (or in a parallel pathway to) the EGF-R in the wing.
The second, most penetrant phenotype was the appearance of humeral outgrowths in UAS-SOCS/en-GAL4 flies. Interestingly, mutants with a temperaturesensitive allele of d-stat (d-stat F ) develop similar UAS-SOCS-45; d-cbl, e/TM3, Sb or UAS-SOCS-45 flies were crossed to the en-GAL4 driver (e16e) at 278C. The F1 adults from these crosses were scored for absent wing ACVs and humeral outgrowths as described in the text outgrowths at the non-permissive temperature (Baska et al., submitted for publication). Removing one copy of either the egf-r or d-cbl genes had minimal effect on either the penetrance or severity of this phenotype. However, flies heterozygous for either stat92E or hop (data not shown) resulted in a strong enhancement of the outgrowth phenotype. These observations further support the ability of SOCS36E to negatively modulate JAK/STAT signalling in the wing disc. This conclusion is also borne out by our observation that ap-GAL4-mediated expression of SOCS36E results in outstretched wings similar to that seen for regulatory alleles of upd (Harrison et al., 1998) . The outstretched wing phenotype was partially suppressed in flies heterozygous for d-cbl (data not shown) suggesting that proper wing and muscle development integrates signals modulated by JAK/STAT and Cbl activities. A surprising finding was the eye pigmentation defect in en-GAL4/UAS-SOCS flies. Pigmentation was not uniform but rather restricted to the engrailed expression domain in the adult eye. This was specific to the expression of SOCS protein and did not require a functional SH2 or SOCS-box domain. Although the mechanism remains to be elucidated, our observation supports the notion that the N-terminus of SOCS36E might contain a novel motif that modulates SOCS protein function, independently of the SH2 and SOCSbox domains.
The data presented in this study clearly indicates that SOCS36E can interact with and suppress the JAK/ STAT pathway in vivo. Although SOCS36E is most closely related to SOCS-5, the fact that SOCS36E can suppress JAK/STAT signalling in flies makes it functionally related to CIS and SOCS-1 -3. SOCS-1 -3 have been shown to suppress c-kit (De Sepulveda et al., 1999) , PDGF (Cacalano et al., 2001) , insulin (Emanuelli et al., 2000) and IGF-I (Metcalf et al., 2000) signalling indicating that SOCS proteins also regulate several receptor tyrosine kinase pathways. This appears to also be true for SOCS36E as we show, in vivo, an interaction with EGF-R signalling in flies. It is tempting to speculate that mammalian SOCS-5, because of its close homology to SOCS36E, will also share this function. Future studies of SOCS-5 will address this possibility.
Searching the entire Drosophila genome indicates that there are at least two other socs genes in flies, socs16D and socs44A. Consequently, the fly SOCS proteins may have broader specificity than those described for their mammalian counterparts. Whether they will serve as broad or restricted regulators of various tyrosine phosphorylation signalling cascades remains to be seen. The isolation of d-socs mutants should help resolve this important question.
Materials and methods
cDNAs and antibodies
Anti-HA antibodies 12CA5 and Y11 were purchased from Roche Biochemicals (Indianapolis, IN, USA) and Santa Cruz (Santa Cruz, CA, USA), respectively. Embryonic Drosophila cDNA libraries and the Drosophila expression plasmids, pAct5C and pUASp, were provided by Norbert Perrimon, Harvard Medical School (Boston, MA, USA).
Molecular cloning of socs36E
A 256 bp fragment (encoding a sequence homologous to the C-terminus of murine SOCS-5) was amplified from Ore R genomic DNA using the polymerase chain reaction (PCR); sense primer: 5'-CTGCCACGATCCGTGTGTGTT-3'; antisense primer: 5'-GACGCGCAGCTTCTGCTTGTA-3'. The amplified product was subcloned into pBluescript (Stratagene, La Jolla, CA, USA) to generate pBS-socs36E-probe. 6 clones were isolated from an embryonic (4 -8 h) cDNA plasmid library (Brown and Kafatos, 1988) by virtue of their hybridization to a 32 P-labelled socs36E probe. These were subjected to a second round of selection for their ability to direct amplification of a predicted 511 bp socs36E fragment (sense primer: 5'-GCAACATGACCGTGCACTCGCAA-3' and anti-sense primer: 5'-GACGCGCAGCTTCTGCTTG-TA-3'). Of two positive clones identified, one contained a 3.5 kb insert that was sequenced in its entirety.
Generation of cDNA constructs
The wild-type (WT), 1902 bp coding region of socs36E was subcloned into pBluescript after adding unique KpnI and XbaI restriction sites to the 5' and 3' ends respectively (pBS-SOCS-WT). The SH2 mutant (pBS-SOCS-SH2*) was engineered using the Quickchange site-directed mutagenesis kit (Stratagene) to substitute arginine (Arg 500 ) with lysine. A SOCS-box deficient mutant (pBS-SOCS-DSB) was obtained by deleting the final 60 amino acids from the C-terminus of SOCS36E. A tagged version of socs36E WT cDNA was generated by PCR by adding, in frame, two hemagglutinin (HA) tags to the N-terminus of SOCS36E. The tagged cDNA was cloned into the fly expression vector pAct5C. pAct5C-Neo R : A unique 1.2 kb HindIII/XbaI neomycin-resistance gene was first subcloned into pBS to facilitate its cloning into the KpnI/NotI sites of pAct5C. All cDNAs were purified using Qiagen Maxi-prep kits (Qiagen, Valencia, CA, USA). 
Fly strains
Generation of SOCS36E-transgenic flies
Non-tagged WT, SH2* and DSB socs36E cDNAs were subcloned into the unique KpnI/XbaI sites of pUASp (Rorth, 1998) . w 1118 embryos were co-injected with pUASp-socs36E cDNAs and a plasmid encoding the D2-3 transposase. Germline transmission was confirmed by monitoring expression of the mini-white gene. Two transgenic lines carrying the WT socs36E cDNA (UAS-SOCS-45 and -15) were independently recombined with en-GAL4 on the second chromosome. The two recombinants were maintained over the CyO balancer. 
Cell culture and transfections
Schneider S2 and mbn-2 cells were continuously grown in Schneider's Insect media supplemented with 10% (v/v) foetal bovine serum (Hyclone, Logan, UT, USA), penicillin G (50 U/ml), streptomycin (50 mg/ml) and L-glutamine (2 mM) in a humidified atmosphere at 258C. Mbn-2 cells stably expressing HA-SOCS36E were obtained after co-transfection of pAct5C-HA-socs36E and pAct5C-Neo R plasmid cDNAs and selection in medium containing 2.25 mg/ml G418 (Mediatech, Inc., Herndon, VA, USA).
Northern hybridizations
RNA samples were isolated using Trizol (Gibco -BRL, Grand Island, NY, USA) according to the manufacturer's directions. Total RNA (5 -15 mg) was fractionated on formaldehyde/agarose gels, transferred to Duralon-UV TH membrane (Stratagene) and fixed by UV cross-linking. Membranes were prehybridized in Rapid-Hyb (Amersham; Arlington Heights, IL, USA) at 688C for 30 min. Hybridization with 32 P-radiolabelled socs36E probe was carried out at 688C for 1 h in the presence of denatured salmon sperm DNA. After washing, membranes were exposed to film at 7808C.
In situ hybridizations
In situ mRNA hybridization of Drosophila embryos was performed according to Tautz and Pfeifle (1989) . Hybridization was carried out overnight at 588C with DIG-labelled RNA probes. Anti-DIG/alkaline phosphatase conjugated antibody (Roche) (1 : 2000) was added for 1 h at room temperature. After thorough washing, alkaline phosphatase activity was detected according to the manufacturer's specifications (Roche). Anti-sense or sense DIG-labelled probes were generated from pBS-socs36E-probe linearized with either BamHI or NotI, respectively, using a DIG-RNA labelling kit (Roche).
Immunoprecipitations and immunoblotting
Mbn-2 cells were lysed on ice with KALB buffer (50 mM Tris.HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM Na 3 VO 4 , 1 mM NaF) supplemented with protease inhibitors. Clarified supernatants were used in immunoprecipitation reactions performed for 4 -16 h at 48C in the presence of antibody and protein A-sepharose (Pharmacia, Piscataway, NJ, USA). Immune complexes were separated by sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS -PAGE). Following transfer to Immobilon-P polyvinylidene difluoride (PVDF) membrane (Millipore; Bedford, MA, USA), blocking solution was added prior to incubation with the primary antibody. Membranes were washed with TBST and incubated with a 1 : 5000 dilution of horseradish peroxidase-conjugated secondary antibody (Amersham) in 1.3% of BSA/TBST for 30 min at room temperature. After washing, immunoreactive proteins were detected using enhanced chemiluminescence reagent (Amersham).
